Fragile X syndrome (FXS) is a cognitive disorder caused by silencing of the fragile X mental retardation 1 gene (FMR1) in both males and females with a full mutation. The subsequent lack of FMR1 protein FMRP leads to the dysregulation of hundreds of proteins that affect synaptic plasticity and connectivity in the developing brain leading to intellectual disability (ID) and other clinical features of the syndrom
Creative Biolabs offers expert services for the development of antibodies targeting the F13L protein of monkeypox virus (MPXV), a vital component in understanding the pathogenesis of the virus and its immune evasion mechanisms. The F13L gene of monkeypox encodes a protein that plays a crucial role in the virus's ability to inhibit host immune responses, particularly the antiviral activity of interferons. As MPXV continues to be a global health concern, antibody-based research tools against this protein have become pivotal for studying viral replication, immune modulation, and potential vaccine development.